Underuse of Effective Cardiac Medications Among Women, Middle-Aged Adults, and Racial/Ethnic Minorities With Coronary Artery Disease (from the National Health and Nutrition Examination Survey 2005 to 2014)

Authors

Hoang V. Tran, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.
Molly E. Waring, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.
David D. McManus, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Massachusetts Medical School, Worcester, MA.
Nathaniel Erskine, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.
Van T. Do, Internal Medicine, Department of Medicine, Bridgeport Hospital-Yale Medicine, Bridgeport, CT.
Catarina I. Kiefe, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.
Robert J. Goldberg, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA. Electronic address: Robert.Goldberg@umassmed.edu.

Document Type

Article

Publication Title

The American journal of cardiology

Abstract

Given the proven effectiveness of several cardiac medications for patients with coronary artery disease (CAD), we examined the national use of 4 classes of effective medications, overall and by age, sex, and race/ethnicity in 2005 to 2014. We used data from the National Health and Nutrition Examination Survey, including a self-reported diagnosis of CAD and independently verified medication use. Weighting procedures extrapolated our data to the adult US population with CAD. Analyses included 1,789 US adults aged ≥45 years with a history of CAD. The average age of this population was 68 years; 40% were women and 79% were non-Hispanic whites. In 2005 to 2014, 53.2% (standard error [SE] = 1.5) reported use of angiotensin-converting enzyme inhibitor/angiotensin receptor blockers, 58.5% (SE = 1.5) β blockers, and 67.2% (SE = 1.4) statins. Two of these medications were used by 64.1% (SE = 1.5) of the study population and all 3 by 29.1% (SE = 1.3). In 2011 to 2014, 68.5% (SE = 2.4) of American adults with a history of CAD reported use of aspirin. The use of statins increased from 63.1% in 2005/2006 to 76.8% in 2013/2014. Adults aged 45 to 64 years old, women, and racial/ethnic minorities had lower use of effective cardiac medications compared with older adults, men, and non-Hispanic whites. In conclusion, the use of statins, but not other medications, has increased over the past 10 years among American adults with previously diagnosed CAD. Continued targeted efforts are needed to increase the receipt of effective cardiac medications among all US adults with CAD, especially those aged 45 to 64 years, women, and racial/ethnic minorities.

First Page

1223

Last Page

1229

DOI

10.1016/j.amjcard.2017.07.004

Publication Date

10-15-2017

Recommended Citation

Tran, Hoang V.; Waring, Molly E.; McManus, David D.; Erskine, Nathaniel; Do, Van T.; Kiefe, Catarina I.; and Goldberg, Robert J., "Underuse of Effective Cardiac Medications Among Women, Middle-Aged Adults, and Racial/Ethnic Minorities With Coronary Artery Disease (from the National Health and Nutrition Examination Survey 2005 to 2014)" (2017). All Research. 237.
https://scholar.bridgeporthospital.org/all_research/237

Identifier

28822562 (pubmed); 10.1016/j.amjcard.2017.07.004 (doi); S0002-9149(17)31168-2 (pii)